H. Shelton Earp, M.D.

H. Shelton Earp M.D. is the Director of the Lineberger Comprehensive Cancer Center and a professor of Medicine and Pharmacology at the University of North Carolina/Chapel Hill. He has spearheaded studies into Human EGF Receptor-4, HER4, which is believed to be a tumor suppressor and can be used to predict a good prognosis in breast cancer. For the full story on Dr. Earp, click <a target="_blank"href="http://www.bcrfcure.org/action_meetres_earp.html">here.</a>

( The Breast Cancer Research Foundation. / October 16, 2009 )

H. Shelton Earp M.D. is the Director of the Lineberger Comprehensive Cancer Center and a professor of Medicine and Pharmacology at the University of North Carolina/Chapel Hill. He has spearheaded studies into Human EGF Receptor-4, HER4, which is believed to be a tumor suppressor and can be used to predict a good prognosis in breast cancer. For the full story on Dr. Earp, click here.

  • Email E-mail
  • add to Twitter Twitter
  • add to Facebook Facebook

PLAN AHEAD

Top Trending Videos